5G Investment News
  • Top News
  • Economy
  • Forex
  • Investing
  • Stock
  • Editor’s Pick
No Result
View All Result
5G Investment News
  • Top News
  • Economy
  • Forex
  • Investing
  • Stock
  • Editor’s Pick
No Result
View All Result
5G Investment News
No Result
View All Result
Home Stock

Viability concerns stall Ayala hospital arm’s bid for P9.49-B PGH cancer center

by
January 28, 2024
in Stock
0
Viability concerns stall Ayala hospital arm’s bid for P9.49-B PGH cancer center
RAMILTIBAYAN/CC BY-SA 4.0/WIKIMEDIA COMMONS

THE Ayala group’s hospital brand is facing challenges in bidding for the P9.49-billion Philippine General Hospital (PGH) cancer center due to concerns about economic viability, an official said.

“No movement right now because when we looked at the terms of reference, it is quite difficult to make it really viable,” Jaime E. Ysmael, Healthway Medical Network chief executive officer, told reporters last week.

“The government is now studying if they can modify the terms,” he added.

Healthway Medical Network is the hospitals and clinics arm of Ayala Healthcare Holdings, Inc. (AC Health). 

“It is more of the economics. It is difficult to really make it work considering that you’re building a big hospital that will address both charity and private patients,” Mr. Ysmael said.

“You can get earnings from the private patients but we will not earn anything from the charity side,” he added.

Building a large hospital for both charity and private patients poses economic challenges, with complexities in the build-transfer-operate model, according to the company.

“Even the assets will not be with the proponent; it is hard also to get loans if that is the case,” he added.

The cancer center project, with a 300-bed capacity, began bidding in June last year, aiming to enhance the existing University of the Philippines-PGH cancer facility.

In November, the company inaugurated the P3 billion Healthway Cancer Care Hospital  in Taguig City, featuring specialized facilities and services.

AC Health’s diverse portfolio includes Healthway, Generika Drugstore, IE Medica, MedEthix, and the healthcare aggregator app KonsultaMD. — Revin Mikhael D. Ochave

Previous Post

Unlocking global opportunities: Studying abroad made easier with accessible and reliable payment platforms

Next Post

Beyond makeup: L’Oreal’s Beauty Academy now extends to social media training

Next Post
Beyond makeup: L’Oreal’s Beauty Academy now extends to social media training

Beyond makeup: L’Oreal’s Beauty Academy now extends to social media training

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.







    Fill Out & Get More Relevant News





    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.
    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recommended

    Hived raises $42m to roll out electric delivery fleet across southern England

    Hived raises $42m to roll out electric delivery fleet across southern England

    July 5, 2025
    Tesla sees UK sales rebound in June as EV market accelerates

    Tesla sees UK sales rebound in June as EV market accelerates

    July 5, 2025
    ‘Invest in Women’ fund criticised for slow rollout as MPs call for bolder action

    ‘Invest in Women’ fund criticised for slow rollout as MPs call for bolder action

    July 5, 2025
    “A turning point for education”: James Caan launches bold education reform plan in House of Lords

    “A turning point for education”: James Caan launches bold education reform plan in House of Lords

    July 5, 2025

    Disclaimer: 5GInvestmentNews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 5GInvestmentNews. All Rights Reserved.

    No Result
    View All Result
    • Home
    • Privacy Policy
    • suspicious engagement
    • Terms & Conditions
    • Thank you

    © 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.